183 related articles for article (PubMed ID: 23526547)
1. Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation.
Jiang Y; Singh P; Yin H; Zhou YX; Gui Y; Wang DZ; Zheng XL; ;
J Cell Physiol; 2013 Oct; 228(10):1989-95. PubMed ID: 23526547
[TBL] [Abstract][Full Text] [Related]
2. Atrogin-1 Increases Smooth Muscle Contractility Through Myocardin Degradation.
Singh P; Li D; Gui Y; Zheng XL
J Cell Physiol; 2017 Apr; 232(4):806-817. PubMed ID: 27403897
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation.
Miki Y; Morioka T; Shioi A; Fujimoto K; Sakura T; Uedono H; Kakutani Y; Ochi A; Mori K; Shoji T; Emoto M; Inaba M
Biochem Biophys Res Commun; 2019 Aug; 516(3):951-956. PubMed ID: 31272716
[TBL] [Abstract][Full Text] [Related]
4. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
[TBL] [Abstract][Full Text] [Related]
7. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
8. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
10. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.
Du KL; Ip HS; Li J; Chen M; Dandre F; Yu W; Lu MM; Owens GK; Parmacek MS
Mol Cell Biol; 2003 Apr; 23(7):2425-37. PubMed ID: 12640126
[TBL] [Abstract][Full Text] [Related]
11. Myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation.
Long X; Creemers EE; Wang DZ; Olson EN; Miano JM
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16570-5. PubMed ID: 17940050
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
13. Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.
Wang H; Liu D; Cao P; Lecker S; Hu Z
Diabetes; 2010 Aug; 59(8):1879-89. PubMed ID: 20522589
[TBL] [Abstract][Full Text] [Related]
14. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box.
Doi H; Iso T; Yamazaki M; Akiyama H; Kanai H; Sato H; Kawai-Kowase K; Tanaka T; Maeno T; Okamoto E; Arai M; Kedes L; Kurabayashi M
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2328-34. PubMed ID: 16151017
[TBL] [Abstract][Full Text] [Related]
15. Contribution of serum response factor and myocardin to transcriptional regulation of smoothelins.
Rensen SS; Niessen PM; Long X; Doevendans PA; Miano JM; van Eys GJ
Cardiovasc Res; 2006 Apr; 70(1):136-45. PubMed ID: 16451796
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ubiquitin proteasome pathway molecular markers in response to endurance and resistance exercise and training.
Stefanetti RJ; Lamon S; Wallace M; Vendelbo MH; Russell AP; Vissing K
Pflugers Arch; 2015 Jul; 467(7):1523-1537. PubMed ID: 25104573
[TBL] [Abstract][Full Text] [Related]
17. Myocardin: a component of a molecular switch for smooth muscle differentiation.
Chen J; Kitchen CM; Streb JW; Miano JM
J Mol Cell Cardiol; 2002 Oct; 34(10):1345-56. PubMed ID: 12392995
[TBL] [Abstract][Full Text] [Related]
18. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
19. Adipocytes suppress differentiation of muscle cells in a co-culture system.
Seo K; Suzuki T; Kobayashi K; Nishimura T
Anim Sci J; 2019 Mar; 90(3):423-434. PubMed ID: 30585366
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on the expression of atrogin-1/MAFbx in chick skeletal muscle.
Nakashima K; Ishida A; Ijiri D; Ohtsuka A
Anim Sci J; 2016 Mar; 87(3):405-10. PubMed ID: 26279163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
